2016
DOI: 10.1200/jco.2016.34.15_suppl.e22001
|View full text |Cite
|
Sign up to set email alerts
|

Subependymal giant cell astrocytoma in pediatric patients with tuberous sclerosis complex treated with mTOR inhibitors: One center experience.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…and everolimus, an mTOR inhibitors, has been shown to reduce the size of subependymal gaint cell tumors in TSC 3. 5.…”
mentioning
confidence: 99%
“…and everolimus, an mTOR inhibitors, has been shown to reduce the size of subependymal gaint cell tumors in TSC 3. 5.…”
mentioning
confidence: 99%